Ephrin tempers two-faced synaptojanin 1.
Hopper
Neil A
NA
O'Connor
Vincent
V
D000818:Animals; D004705:Endocytosis / Q000187:drug effects / Q000235:genetics / Q000502:physiology; D011992:Endosomes / Q000378:metabolism; D036388:Ephrin-B2 / Q000378:metabolism; D006801:Humans; D009154:Mutation; D016202:N-Methylaspartate / Q000494:pharmacology; D009419:Nerve Tissue Proteins / Q000235:genetics / Q000378:metabolism*; D019269:Phosphatidylinositol 4,5-Diphosphate / Q000378:metabolism; D010744:Phosphoric Monoester Hydrolases / Q000235:genetics / Q000378:metabolism*; D019000:Phosphotyrosine / Q000378:metabolism*; D036183:Receptor, EphB2 / Q000235:genetics / Q000378:metabolism*; D018091:Receptors, AMPA / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects / Q000235:genetics / Q000502:physiology
D036388:Ephrin-B2; D009419:Nerve Tissue Proteins; D019269:Phosphatidylinositol 4,5-Diphosphate; D018091:Receptors, AMPA; D019000:Phosphotyrosine; D016202:N-Methylaspartate; D036183:Receptor, EphB2; C097702:synaptojanin; D010744:Phosphoric Monoester Hydrolases